Pediatric Inpatient Insulin Pump Use and Glycemic Control

Abstract

Owens et al 1 present a retrospective study regarding the safety of home and hospital-provided insulin pump therapy during hospitalization in a cohort of young patients. The authors describe more than 18 000 days of subcutaneous insulin use in noncritically ill pediatric, adolescent, and young adult patients across multiple inpatient pediatric units, including a dedicated diabetes unit, but also medical, surgical, pulmonary, oncology, and psychiatry units, in a single pediatric hospital system. To